Leadership Overview
Alcami has 7 executives leading key functions including strategy, operations, information technology, human resources, and drug product development.
Driven by a commitment to advancing health, Alcami is dedicated to providing comprehensive contract development and manufacturing solutions, empowering pharmaceutical and biotech partners to bring life-changing therapies to market with speed and precision.
Driven by a commitment to advancing health, Alcami is dedicated to providing comprehensive contract development and manufacturing solutions, empowering pharmaceutical and biotech partners to bring life-changing therapies to market with speed and precision.
Leadership Roles at Alcami
Roz Stone - Earthware Enterprise Chief Executive Officer
Roz Stone, the Earthware Enterprise Chief Executive Officer at Alcami, directs the overarching corporate strategy and operational framework. Stone's leadership guides the company's mission to accelerate product development for pharmaceutical and biotech clients, leveraging Alcami's extensive facilities and expertise. This executive role involves setting the vision for innovation across all service lines, including analytical development, sterile and oral solid manufacturing, and packaging. Stone ensures alignment with market demands and regulatory standards, driving the company's growth and market position. The focus remains on delivering integrated solutions that span the entire product lifecycle, from early-stage development to commercialization. Stone's strategic direction underpins Alcami's commitment to client success and the advancement of global health initiatives. This leadership position is critical for maintaining Alcami's reputation as a premier contract development and manufacturing organization.
Guy Kubi - Chief Operating Officer
Guy Kubi, the Chief Operating Officer at Alcami, oversees the execution of daily operations across the company's extensive United States facilities. Kubi's responsibilities encompass managing the 675,000 ft of operational space, ensuring seamless integration of services such as analytical development, clinical to commercial manufacturing, and packaging. This role is pivotal in optimizing Alcami's operational efficiency and capacity to meet the diverse needs of pharmaceutical and biotech partners. Kubi drives initiatives focused on enhancing manufacturing processes, maintaining stringent quality control, and ensuring timely delivery of products. The Chief Operating Officer also plays a key part in resource allocation and operational scaling to support client projects from development through commercial launch. Guy Kubi's operational oversight is fundamental to Alcami's ability to provide innovative and customizable solutions, reinforcing the company's position in the contract development and manufacturing sector.

Scott Chadwick - President
Scott Chadwick, the President at Alcami, drives strategic initiatives and business development across the organization. Chadwick's leadership focuses on expanding Alcami's market reach and strengthening relationships with pharmaceutical and biotech clients. This executive position involves overseeing key business functions and ensuring the company's services align with evolving industry needs. Scott Chadwick plays a crucial role in identifying new opportunities for growth and innovation within the contract development and manufacturing landscape. The President's focus is on enhancing Alcami's value proposition by delivering integrated solutions that accelerate product lifecycles. Chadwick's strategic vision contributes significantly to Alcami's reputation for excellence and its commitment to advancing healthcare solutions through reliable manufacturing and development services.
Tori Arens - President, Drug Product
Tori Arens, the President, Drug Product at Alcami, directs the comprehensive strategy and operations for drug product development and manufacturing. Arens oversees all aspects of sterile and oral solid dosage form production, ensuring adherence to the highest quality and regulatory standards. This leadership role is critical for managing Alcami's capabilities in clinical to commercial manufacturing, packaging, and related services. Tori Arens focuses on optimizing production processes, enhancing capacity, and driving innovation within the drug product division to meet the complex needs of pharmaceutical and biotech clients. The President, Drug Product ensures seamless integration of services, supporting clients from early-stage development through market launch. Arens's expertise is vital for Alcami's commitment to delivering reliable and efficient drug product solutions.

Katie Schlipp - President, Laboratory Operations
Katie Schlipp, the President, Laboratory Operations at Alcami, leads the extensive analytical development and microbiology services. Schlipp oversees the operations within Alcami's state-of-the-art laboratories, ensuring the delivery of precise and reliable analytical testing and support services. This executive role is fundamental to providing pharmaceutical and biotech partners with critical data for product development and quality control. Katie Schlipp directs teams focused on environmental monitoring, microbiology, and a wide array of analytical testing methodologies. The President, Laboratory Operations ensures that Alcami's laboratory services meet stringent cGMP requirements and support clients throughout the product lifecycle. Schlipp's leadership is key to maintaining Alcami's reputation for scientific excellence and comprehensive laboratory support.
Tariq Jamal - Chief Information Officer
Tariq Jamal, the Chief Information Officer at Alcami, directs the company's technology strategy and digital infrastructure. Jamal is responsible for implementing and managing the IT systems that support Alcami's comprehensive contract development and manufacturing operations. This includes ensuring robust data security, enhancing operational workflows through technology, and enabling seamless communication across all departments and client interactions. The Chief Information Officer's role is critical in leveraging technology to drive innovation in analytical development, manufacturing, and supply chain management. Tariq Jamal focuses on developing scalable IT solutions that support Alcami's growth and its mission to serve pharmaceutical and biotech companies effectively. This leadership ensures that Alcami maintains a competitive edge through advanced technological capabilities, supporting the company's commitment to delivering high-quality services.
Rose-Marie Nelson - Chief Human Resources Officer
Rose-Marie Nelson, the Chief Human Resources Officer at Alcami, leads all aspects of human capital management and organizational development. Nelson is instrumental in cultivating a high-performance culture that supports Alcami's mission of advancing pharmaceutical and biotech products. This executive role involves developing strategies for talent acquisition, employee engagement, and professional development across the organization's extensive operations. Rose-Marie Nelson ensures that Alcami attracts and retains top talent, fostering an environment conducive to innovation and collaboration. The Chief Human Resources Officer also oversees compensation, benefits, and compliance, aligning HR practices with the company's strategic objectives. Nelson's leadership is vital for building a skilled workforce capable of meeting the complex demands of contract development and manufacturing services.

Explore Leadership Teams in Manufacturing
Jubilant Pharmova is a patient-focused biopharmaceutical company based in Noida, India.
Company Leadership AC

SJ
VK
Madrigal Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The company's lead candidate is MGL-3196, an orally administered, small-molecule, liver-directed, thyroid hormone receptor (THR) -selective agonist, which is in Phase II clinical trials for the treatment of non-alcoholic steatohepatitis and heterozygous familial hypercholesterolemia.
Company Leadership
RF
CW
SK
Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle. With over 40 years of experience and a growing team of experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing. Cambrex offers a range of specialized drug substance technologies and capabilities, including continuous flow, controlled substances, solid-state science, material characterization, stability storage, and highly potent APIs. In addition, Cambrex can support conventional dosage forms, including oral solids, semi-solids, and liquids, and has the expertise to manufacture specialty dosage forms such as modified-release, fixed-dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile, and non-sterile ointments.
Company Leadership
BB

RL
Founded in 1994 and headquartered in Shanghai, China, Fosun Pharma is a company that focuses on the research and development and manufacturing of pharmaceuticals.
Company Leadership AD
AH
YS
LC